Cellectar Share Price

Cellectar Share Price

NASDAQ: CLRB | Micro Cap | Healthcare
$0.81
-$0.08 (-8.8%) Last updated on 21 Nov, 2026 | 00:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cellectar Stock Performance

Open
$0.90
Prev. Close
$0.88
Circuit Range
N/A
Day Range
$0.81 - $0.90
Year Range
$0.81 - $4.68
Volume
628
Average Traded
$0.85

Cellectar Share Price Today

As of 21 November 2026, Cellectar Biosciences, Inc.'s share price is $0.81. The stock opened at $0.90, compared to its previous close of $0.88. During today's trading session, Cellectar Biosciences, Inc.'s share price traded between $0.81 and $0.90, with an average price of $0.85. Over the past 52 weeks, the stock has recorded a high of $4.68 and a low of $0.81. In terms of performance, Cellectar Biosciences, Inc.'s share price has declined by 74.99% over the last six months and is down 77.70% on a year-on-year basis.

Cellectar Share Price Chart

Line chart of the Cellectar price trend over the selected period. The price fell overall, ranging from 0.81 to 0.90, ending at 0.81.
$0.81$0.90
L
Show Current Price
H

Cellectar Stock Fundamentals & Key Indicators

Market Cap
$2.10M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.58
Revenue (TTM)
$0.00
Return On Equity (TTM)
-115.34%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-50.38%

Cellectar Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.30-$5.65-$6.93-$7.97
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-6.60%-22.65%-15.01%

Cellectar Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$31.79-$42.77-$44.58-$21.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.54%-4.23%51.12%

Cellectar Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.941.221.621.06
Current Assets14.0424.2510.4520.53
Total Assets14.9825.4712.0821.59
Non Current Liabilities0.310.410.490.55
Current Liabilities4.759.3925.3611.5
Total Liabilities5.069.825.8512.05
Shareholders' Equity8.5414.29-15.168.15

Cellectar Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-23.12-47.58-32.38-25.22
Investing-0.01-0.1-0.86-0.23
Financing13.0361.4122.949.61

Corporate Actions

Split
Ex-date: 24 Jun 2025

Split
Ex-date: 22 Jul 2022

Split
Ex-date: 17 Jul 2018

About Cellectar

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Cellectar Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.21
$0.81
-33.20%
Oct 2026
$1.86
$1.21
-34.51%
Sep 2026
$2.45
$1.84
-26.98%
Aug 2026
$2.60
$2.52
-3.82%
Jul 2026
$2.83
$2.62
-6.43%
Jun 2026
$3.12
$2.80
-13.04%
May 2026
$2.64
$3.22
+22.43%
Apr 2026
$2.87
$2.63
+6.48%
Mar 2026
$3.02
$2.47
-26.27%
Feb 2026
$3.11
$3.35
+5.68%
Jan 2026
$3.56
$3.17
+9.31%
Dec 2025
$3.58
$2.90
-19.67%

Cellectar Share Price FAQs